Justin Saekseditorial@labpulse.comMolecular DiagnosticsA look at how COVID-19 testing varies by world regionWorldwide demand for COVID tests has materialized rapidly from zero and is on course to become a $1.3 billion market in the first half of 2020, according to Kalorama Information's report on molecular diagnostic markets in the COVID-19 era.July 26, 2020Regulatory ApprovalWorld market outlook: COVID-19 testing evolves rapidly, lessons sink inWorldwide, COVID-19 testing volume was on target to grow 25%-30% from May to June. New products and services are continually being introduced, and regulatory approvals have been growing and expanding to include more types of tests, samples, and sample collection methods.June 28, 2020InfectiousCOVID-19 testing presents learning curve for all involvedAs of April 22, around 4.5 million COVID-19 diagnostic tests had been performed in the U.S., which began large-scale testing in early March. There is still some uncertainty regarding what level of testing is needed in the long term, partly due to unknowns about the chances for success of countries' efforts to stop the disease's spread. Other unknown variables include the current disease prevalence and the schedules for rolling back shelter-in-place orders.April 23, 2020Health TopicsMolecular testing and COVID-19: Where are we now?Countries have been trying to apply the lessons learned in the regions that were hit first. China appears to have dramatically slowed the disease, and one of the key aspects of that effort has been large-scale diagnostic testing.Tests that received EUAs as of March 24March 25, 2020Page 1 of 1Top StoriesAgreementBioMérieux subsidiary secures DoD contract for infectious disease testing systemBioFire Defense, a subsidiary of BioMérieux, has secured an order-dependent contract with the U.S. Department of Defense (DoD) to provide support for a military-use version of its multiplex polymerase chain reaction infectious disease test system.SchizophreniaGenetic predisposition to smoking may drive schizophrenia heart disease risk: StudyFinancingHarbinger Health raises $140M in series B fundingMalariaStudy shows malaria drug resistance occurring in Horn of AfricaSponsor ContentLatest in at-home or lab-based STI testing